Oxidative modification and down-regulation of Pin1 in Alzheimer's disease hippocampus: A redox proteomics analysis
- PMID: 15950321
- DOI: 10.1016/j.neurobiolaging.2005.05.005
Oxidative modification and down-regulation of Pin1 in Alzheimer's disease hippocampus: A redox proteomics analysis
Abstract
Alzheimer disease (AD) is characterized neuropathologically by intracellular neurofibrillary tangles (NFT) and of extracellular senile plaques (SP), the central core of which is amyloid beta-peptide (Abeta) derived from amyloid precursor protein (APP), a transmembrane protein. AD brain has been reported to be under oxidative stress that may play an important role in the pathogenesis and progression of AD. The present proteomics study is focused on identification of a specific target of protein oxidation in AD hippocampus that has relevance to the role of oxidative stress in AD. Here, we report that the protein, Pin1, is significantly down-regulated and oxidized in AD hippocampus. The identity of Pin1 was confirmed immunochemically. Analysis of Pin1 activity in AD brain and separately as oxidized pure Pin1 demonstrated that oxidation of Pin1 led to loss of activity. Pin1 has been implicated in multiple aspects of cell cycle regulation and dephosphorylation of tau protein as well as in AD. The in vivo oxidative modification of Pin1 as found by proteomics in AD hippocampus in the present study suggests that oxidative modification may be related to the known loss of Pin1 isomerase activity that could be crucial in AD neurofibrillary pathology. Taken together, these results provide evidence supporting a direct link between oxidative damage to neuronal Pin1 and the pathobiology of AD.
Similar articles
-
Redox proteomics identification of oxidatively modified hippocampal proteins in mild cognitive impairment: insights into the development of Alzheimer's disease.Neurobiol Dis. 2006 May;22(2):223-32. doi: 10.1016/j.nbd.2005.11.002. Epub 2006 Feb 8. Neurobiol Dis. 2006. PMID: 16466929
-
Pin1 in Alzheimer's disease.J Neurochem. 2006 Sep;98(6):1697-706. doi: 10.1111/j.1471-4159.2006.03995.x. J Neurochem. 2006. PMID: 16945100 Review.
-
Pin1 promotes degradation of Smad proteins and their interaction with phosphorylated tau in Alzheimer's disease.Neuropathol Appl Neurobiol. 2014 Dec;40(7):815-32. doi: 10.1111/nan.12163. Neuropathol Appl Neurobiol. 2014. PMID: 24964035
-
The prolyl isomerase Pin1 regulates amyloid precursor protein processing and amyloid-beta production.Nature. 2006 Mar 23;440(7083):528-34. doi: 10.1038/nature04543. Nature. 2006. PMID: 16554819
-
Pin1: a new outlook in Alzheimer's disease.Curr Alzheimer Res. 2011 Sep;8(6):615-22. doi: 10.2174/156720511796717140. Curr Alzheimer Res. 2011. PMID: 21605045 Review.
Cited by
-
Proteomic approaches to quantify cysteine reversible modifications in aging and neurodegenerative diseases.Proteomics Clin Appl. 2016 Dec;10(12):1159-1177. doi: 10.1002/prca.201600015. Epub 2016 Nov 11. Proteomics Clin Appl. 2016. PMID: 27666938 Free PMC article. Review.
-
Regional expression of key cell cycle proteins in brain from subjects with amnestic mild cognitive impairment.Neurochem Res. 2007 Apr-May;32(4-5):655-62. doi: 10.1007/s11064-006-9123-x. Epub 2006 Sep 28. Neurochem Res. 2007. PMID: 17006763
-
Yeast as a model system to study tau biology.Int J Alzheimers Dis. 2011 Apr 6;2011:428970. doi: 10.4061/2011/428970. Int J Alzheimers Dis. 2011. PMID: 21559193 Free PMC article.
-
Proteomic analysis of brain proteins in APP/PS-1 human double mutant knock-in mice with increasing amyloid β-peptide deposition: insights into the effects of in vivo treatment with N-acetylcysteine as a potential therapeutic intervention in mild cognitive impairment and Alzheimer's disease.Proteomics. 2011 Nov;11(21):4243-56. doi: 10.1002/pmic.201000523. Epub 2011 Sep 22. Proteomics. 2011. PMID: 21954051 Free PMC article.
-
Neurodegeneration and Alzheimer's disease (AD). What Can Proteomics Tell Us About the Alzheimer's Brain?Mol Cell Proteomics. 2016 Feb;15(2):409-25. doi: 10.1074/mcp.R115.053330. Epub 2015 Dec 11. Mol Cell Proteomics. 2016. PMID: 26657538 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous